Stroke trial doubles disability-free recovery

The trial, which was stopped early because of its success, found 71% of patients achieved functional independence at three months post-operation under the new regime compared to 40% receiving standard care of intravenous alteplase within 4.5 hours of stroke onset.

In the trial of 70 patients, the intervention group received alteplase then underwent endovascular thrombectomy with a new stent device (Solitaire FR, Covidien).

But importantly, researchers say, CT perfusion imaging was used to identify potentially salvageable brain tissue with those patients having large ischaemic cores being excluded.